Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intensity-modulated Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00052429
What this trial is testing

High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 25
Not applicableLooking for participantsNCT06542757
What this trial is testing

Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy

Who this might be right for
Prostate Cancer
NYU Langone Health 91
Testing effectiveness (Phase 2)Study completedNCT04895345
What this trial is testing

TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 25
Not applicableLooking for participantsNCT07376603
What this trial is testing

IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Intensity-modulated RadiotherapyStage IB
Qiaojuan Guo 169
Not applicableActive Not RecruitingNCT03630666
What this trial is testing

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients

Who this might be right for
Prostate CancerOligometastasis
Institut Cancerologie de l'Ouest 256
Testing effectiveness (Phase 2)UnknownNCT05229315
What this trial is testing

PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaT2-3N0 or T1-2N1EBV-DNA≤4000 Copy/ml
XIANG YANQUN 45
Not applicableStudy completedNCT00490282
What this trial is testing

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharyngeal Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00968435
What this trial is testing

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 30
Large-scale testing (Phase 3)UnknownNCT02440191
What this trial is testing

3DCRT vs. IMRT in Early Breast Cancer

Who this might be right for
Radiation Toxicity
Jong Hoon Lee 690
Testing effectiveness (Phase 2)Looking for participantsNCT05965531
What this trial is testing

Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy

Who this might be right for
Rectal Cancer
Sun Yat-sen University 65
Testing effectiveness (Phase 2)UnknownNCT01117402
What this trial is testing

Tomotherapy in Postsurgery Recurrent Carcinoma Cervix

Who this might be right for
Postsurgery Recurrent Carcinoma Cervix
Tata Memorial Hospital 90
Not applicableEnded earlyNCT01148056
What this trial is testing

Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Massachusetts General Hospital 2
Testing effectiveness (Phase 2)Temporarily pausedNCT03164460
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Head and Neck Carcinoma
M.D. Anderson Cancer Center 68
Not applicableUnknownNCT03411408
What this trial is testing

Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma.

Who this might be right for
Malignant GliomaHigh Grade GliomaRecurrent Glioma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 24
Testing effectiveness (Phase 2)Study completedNCT01903408
What this trial is testing

Radiotherapy of the Prostate and the Pelvic Lymph Nodes After Neoadjuvant Antihormonal Treatment

Who this might be right for
Prostate Cancer
Heidelberg University 199
Early research (Phase 1)Looking for participantsNCT06611150
What this trial is testing

Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 24
Testing effectiveness (Phase 2)UnknownNCT04801511
What this trial is testing

Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Zhou Fuxiang 60
Testing effectiveness (Phase 2)Study completedNCT01220752
What this trial is testing

Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)

Who this might be right for
Sinonasal MalignanciesAdenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses
Heidelberg University 36
Large-scale testing (Phase 3)UnknownNCT01216800
What this trial is testing

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

Who this might be right for
Head and Neck CancerOtotoxicityRadiation Toxicity
Institute of Cancer Research, United Kingdom 84
Not applicableLooking for participantsNCT06306170
What this trial is testing

Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

Who this might be right for
Gynecologic CancerRadiotherapy Side EffectRadiotherapy; Complications+3 more
IRCCS San Raffaele 1,000
Next Page